ProstatectomywithRoboticAssist near Jersey City, NJ

Biography: Dr. Luay Alshara is a triple fellowship-trained Endourologist and Robotic Surgeon, who servces as an Associate Professor of Urology at Weill Cornell Medicine and Associate Attending Urology at NewYork-Presbyterian Hospital. He brings years of expertise from his time as a faculty member at Albany Medical College, where he practiced in the New York Capital Region.Dr. Alshara completed his advanced fellowship training in Endourology at Glickman Urological and Kidney Institute at the Cleveland Clinic. He also completed extensive fellowship training in Robotic Surgery at St. Elizabeth's Medical Center Tufts University in Boston and Jackson Health System in Miami.Dr. Alshara is an expert in complex kidney stone surgeries, including various techniques for PCNL (Percutaneous Nephrolithotomy) tailored to the complexity of each patient, ECIRS (Endoscopic Combined Intrarenal Surgery), mini-PCNL, RIRS (Retrograde Intra-Renal Surgery) and robotic assisted stone removal. He also specializes in reconstructive robotic procedures for conditions like ureteral stricture disease and UPJ (ureteropelvic junction) obstruction. Dr. Alshara is an expert in management of large prostate glands, focusing on robotic-assisted prostate surgery and Holmium Laser Enucleation of the Prostate (HoLEP).Committed to advancing patient care, Dr Alshara integrates the latest technologies and techniques into his practice to improve patient outcomes and quality of life. Dr. Alshara is dedicated to offering cutting-edge, minimally invasive surgical solutions, and pioneering advanced programs for prostate laser enucleation using innovative laser technologies.Dr. Alshara has published in the fields of endourology and stone disease, with a focus on improving patient satisfaction, surgical outcomes, and cost-efficiency. Equally committed to education, he is dedicated to mentoring and training the next generation of urologists in the field.

Biography: Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University. Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as "Best Reviewer" in 2014 by The Journal of Urology and in 2016 by Cancer. Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.

Biography: Dr. Gregory Joice, MD is an Urology Specialist who practices in New York, NY. He has been practicing for 11 years. Dr. Gregory Joice, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Andrew T. Lenis, MD MS, is an Assistant Professor of Urology at CUIMC. He specializes in treating patients with bladder, kidney, prostate, testis, and penile cancers. Dr. Lenis graduated from Case Western Reserve University School of Medicine in Cleveland, Ohio, with a dual MD MS degree and Honors Distinction in Research. He then completed his surgical internship and urology residency at UCLA in Los Angeles, California. After residency, Dr. Lenis completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York City. Dr. Lenis joined CUIMC as a surgeon-scientist with an interest and specialization in urothelial cancer (tumors of the bladder, ureter, and renal pelvis). In the laboratory, Dr. Lenis works and collaborates with Michael Shen, Ph.D., who is an expert in bladder and prostate developmental and molecular biology and a pioneer in bladder tumor organoids. The American Urological Association, the American Cancer Society, and the American Society for Clinical Oncology have funded Dr. Lenis' research. His work on urologic malignancies has been published in JAMA, the Journal of Urology, European Urology, the Journal of Clinical Oncology Precision Oncology, and Urologic Oncology. When not seeing patients or in the laboratory, Dr. Lenis enjoys spending time with his wife and two sons. They enjoy the outdoors and traveling.

Biography: Dr. Nachum Katlowitz, MD is an Urology Specialist who practices in Staten Island, NY. He is 70 years old and has been practicing for 44 years. Dr. Nachum Katlowitz, MD is affiliated with Staten Island University Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Izak Faiena MD, MSCR is a urologic oncologist with a specialized focus on prostate cancer. His expertise spans advanced diagnostic techniques, such as MRI fusion and transperineal biopsy, as well as cutting-edge treatments including focal therapy and robotic surgery. With a solid foundation from the Albert Einstein College of Medicine, where he graduated with Alpha Omega Alpha honors, Dr. Faiena went on to complete his urology residency at Rutgers Robert Wood Johnson Medical School. During this time, he earned multiple research awards for his contributions to prostate and bladder cancer studies. Following his residency, Dr. Faiena pursued a fellowship in urologic oncology and earned a Master's in Clinical Research from the esteemed UCLA Institute of Urologic Oncology and the Clinical and Translational Science Institute. His work here garnered significant research funding and resulted in impactful publications on clinical trials in urologic cancers. Currently, Dr. Faiena is dedicated to advancing the field of prostate cancer through innovative clinical trials, targeting both localized and advanced stages of the disease. His groundbreaking research has been featured in top national and international medical journals, reflecting his commitment to improving patient outcomes and advancing cancer care.